URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$35.42
Tradestie Score
57
Market Cap
$824.20M
Revenue Growth
1.5%
Analyst Upside
+4.1%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$39.51
|
$1.84B | - | 56 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.99
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.03
|
$1.78B | - | 58 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.33
|
$1.78B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.32
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$33.78
|
$1.68B | - | 58 | Compare |
|
MNKD
Mannkind Corporation
|
$3.84
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$42.30
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.96
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$41.69
|
$1.56B | 95.0 | 58 | Compare |
More URGN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry